E799 E799
Pill imprint E799 E799 has been identified as Rifampin 300 mg.
Rifampin is used in the treatment of leprosy; meningococcal meningitis prophylaxis; nasal carriage of staphylococcus aureus; tuberculosis, prophylaxis; tuberculosis, latent (and more), and belongs to the drug class rifamycin derivatives. Risk cannot be ruled out during pregnancy.
Rifampin 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Rifampin Images
- Imprint:
-
E799
E799 - Strength:
- 300 mg
- Color:
- Red
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
corn starch
docusate sodium
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
magnesium stearate
microcrystalline cellulose
sodium benzoate
sodium lauryl sulfate
ferrosoferric oxide
magnesium silicate
titanium dioxide
D&C Yellow No. 10
- Drug Class:
- Rifamycin derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Eon
- National Drug Code (NDC):
- 00185-0799
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0890 | UDL Laboratories Inc |
| 63739-0415 | McKesson Packaging Services |
| 00904-5282 | Major Pharmaceuticals |
| 54868-4683 | Physicians Total Care Inc (repackager) |
| 54569-5770 | A S Medication Solutions LLC (repackager) |
| 18837-0329 | Innoviant Pharmacy Inc (repackager) |
| 16590-0714 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Rifampin resources
- Rifampin (Wolters Kluwer)
- Rifampin Capsules (Wolters Kluwer)
- rifampin (Cerner Multum)
- rifampin Intravenous (Micromedex) - Includes Dosage Information
- rifampin Oral, Intravenous (Micromedex) - Includes Dosage Information
- Rifampin (AHFS DI)
- Rifampin Capsules (FDA)
- Rifampin Injection (FDA)
- Rifampin (Wolters Kluwer)
Search Again
